speb/financial-data huggingface dataset:
EMD balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 622009442.00
EMD balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 622009442.00
EMD balance_sheet (quarterly, 2025-06-30) — Total Assets: 880111140.00
EMD balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 852789356.00
EMD balance_sheet (quarterly, 2025-06-30) — Total Debt: 230779914.00
EMD balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 622009442.00
EMD balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 258101698.00
EMD balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 41658.00
EMD income_statement (annual, 2025-12-31) — +Operating Expense: 1369342.00
EMD income_statement (annual, 2025-12-31) — +Total Revenue: 102498509.00
EMD balance_sheet (annual, 2025-12-31) — Accounts Payable: 2960407.00
EMD balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2960407.00
EMD balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 951648147.00
EMD balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 951648147.00
EMD balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 878056963.00
EMD balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 878056963.00
EMD cash_flow (annual, 2025-12-31) — Beginning Cash Position: 500505.00
EMD balance_sheet (annual, 2025-12-31) — Capital Stock: 58130.00
EMD balance_sheet (quarterly, 2025-12-31) — Capital Stock: 58130.00
EMD balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 39708.00
EMD balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 39708.00
EMD balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 932402.00
EMD balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 932402.00
EMD cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -64524792.00
EMD balance_sheet (annual, 2025-12-31) — Cash Financial: 39708.00
EMD balance_sheet (quarterly, 2025-12-31) — Cash Financial: 39708.00
EMD cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 49907.00
EMD cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 0.00
EMD cash_flow (annual, 2025-12-31) — Change In Payable: 2089575.00
EMD cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 109674.00
EMD cash_flow (annual, 2025-12-31) — Change In Receivables: -2481796.00
EMD cash_flow (annual, 2025-12-31) — Change In Working Capital: -232640.00
EMD cash_flow (annual, 2025-12-31) — Changes In Cash: 431897.00
EMD balance_sheet (annual, 2025-12-31) — Common Stock: 58130.00
EMD balance_sheet (quarterly, 2025-12-31) — Common Stock: 58130.00
EMD cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -64524792.00
EMD balance_sheet (annual, 2025-12-31) — Common Stock Equity: 653222775.00
EMD balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 653222775.00
EMD balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 130316.00
EMD balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 130316.00
EMD income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 101129167.00
EMD cash_flow (annual, 2025-12-31) — End Cash Position: 932402.00
EMD cash_flow (annual, 2025-12-31) — Financing Cash Flow: -25744820.00
EMD cash_flow (annual, 2025-12-31) — Free Cash Flow: 26176717.00
EMD cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -61101193.00
EMD income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -6882289.00
EMD income_statement (annual, 2025-12-31) — General And Administrative Expense: 1241548.00
EMD income_statement (annual, 2025-12-31) — Interest Expense: 11058845.00
EMD income_statement (annual, 2025-12-31) — Interest Income: 67992423.00
EMD balance_sheet (annual, 2025-12-31) — Invested Capital: 891992396.00
EMD balance_sheet (quarterly, 2025-12-31) — Invested Capital: 891992396.00
EMD balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 878056963.00
EMD balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 878056963.00
EMD balance_sheet (annual, 2025-12-31) — Investments And Advances: 878056963.00
EMD balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 878056963.00
EMD cash_flow (annual, 2025-12-31) — Issuance Of Debt: 38769621.00
EMD balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 238769621.00
EMD balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 238769621.00
EMD cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 38769621.00
EMD balance_sheet (annual, 2025-12-31) — Net Debt: 238729913.00
EMD balance_sheet (quarterly, 2025-12-31) — Net Debt: 238729913.00
EMD income_statement (annual, 2025-12-31) — Net Income: 101129167.00
EMD income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 101129167.00
EMD income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 101129167.00
EMD income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 101129167.00
EMD income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 101129167.00
EMD cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 101129167.00
EMD income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 101129167.00
EMD income_statement (annual, 2025-12-31) — Net Interest Income: 56933578.00
EMD cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 38769621.00
EMD cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 38769621.00
EMD cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 10351.00
EMD balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 653222775.00
EMD balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 653222775.00
EMD income_statement (annual, 2025-12-31) — Normalized Income: 101129167.00
EMD cash_flow (annual, 2025-12-31) — Operating Cash Flow: 26176717.00
EMD income_statement (annual, 2025-12-31) — Operating Revenue: 102498509.00
EMD balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 58130443.00
EMD balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 58130443.00
EMD cash_flow (annual, 2025-12-31) — Other Non Cash Items: -13618617.00
EMD income_statement (annual, 2025-12-31) — Other Operating Expenses: 127794.00
EMD balance_sheet (annual, 2025-12-31) — Other Payable: 668779.00
EMD balance_sheet (quarterly, 2025-12-31) — Other Payable: 668779.00
EMD balance_sheet (annual, 2025-12-31) — Payables: 3629186.00
EMD balance_sheet (quarterly, 2025-12-31) — Payables: 3629186.00
EMD balance_sheet (annual, 2025-12-31) — Prepaid Assets: 2888.00
EMD balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 2888.00
EMD income_statement (annual, 2025-12-31) — Pretax Income: 101129167.00
EMD balance_sheet (annual, 2025-12-31) — Receivables: 17145978.00
EMD balance_sheet (quarterly, 2025-12-31) — Receivables: 17145978.00
EMD balance_sheet (annual, 2025-12-31) — Retained Earnings: -298483502.00
EMD balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -298483502.00
EMD income_statement (annual, 2025-12-31) — Selling General And Administration: 1241548.00
EMD balance_sheet (annual, 2025-12-31) — Share Issued: 58130443.00
EMD balance_sheet (quarterly, 2025-12-31) — Share Issued: 58130443.00
EMD balance_sheet (annual, 2025-12-31) — Stockholders Equity: 653222775.00
EMD balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 653222775.00
EMD balance_sheet (annual, 2025-12-31) — Tangible Book Value: 653222775.00
EMD balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 653222775.00
EMD income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
EMD income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
EMD balance_sheet (annual, 2025-12-31) — Total Assets: 896138231.00
EMD balance_sheet (quarterly, 2025-12-31) — Total Assets: 896138231.00
EMD balance_sheet (annual, 2025-12-31) — Total Capitalization: 891992396.00
EMD balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 891992396.00
EMD balance_sheet (annual, 2025-12-31) — Total Debt: 238769621.00
EMD balance_sheet (quarterly, 2025-12-31) — Total Debt: 238769621.00
EMD balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 653222775.00
EMD balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 653222775.00
EMD balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 242915456.00
EMD balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 242915456.00
EMD.AX income_statement (annual, 2021-06-30) — +Operating Expense: 5422474.00
EMD.AX income_statement (annual, 2021-06-30) — +Total Revenue: 1207543.00
EMD.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 245520.00
EMD.AX balance_sheet (annual, 2021-06-30) — Accounts Receivable: 139575.00
EMD.AX balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -803320.00
EMD.AX income_statement (annual, 2021-06-30) — Amortization: 67014.00
EMD.AX income_statement (annual, 2021-06-30) — Amortization Of Intangibles Income Statement: 67014.00
EMD.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 3686333.00
EMD.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -661386.00
EMD.AX balance_sheet (annual, 2021-06-30) — Capital Lease Obligations: 949699.00
EMD.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 19310804.00
EMD.AX balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 6528926.00
EMD.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 6528926.00
EMD.AX balance_sheet (annual, 2021-06-30) — Cash Financial: 6528926.00
EMD.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: 7441298.00
EMD.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -661386.00
EMD.AX cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: -3937319.00
EMD.AX cash_flow (annual, 2021-06-30) — Changes In Cash: 2842593.00
EMD.AX cash_flow (annual, 2021-06-30) — Classesof Cash Payments: -6887133.00
EMD.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 2961368.00
EMD.AX balance_sheet (annual, 2021-06-30) — Common Stock: 19310804.00
EMD.AX balance_sheet (annual, 2021-06-30) — Common Stock Equity: 7178217.00
EMD.AX cash_flow (annual, 2021-06-30) — Common Stock Issuance: 8400000.00
EMD.AX cash_flow (annual, 2021-06-30) — Common Stock Payments: -527504.00
EMD.AX income_statement (annual, 2021-06-30) — Cost Of Revenue: 2264272.00
EMD.AX balance_sheet (annual, 2021-06-30) — Current Assets: 6883930.00
EMD.AX balance_sheet (annual, 2021-06-30) — Current Capital Lease Obligation: 197630.00
EMD.AX balance_sheet (annual, 2021-06-30) — Current Debt And Capital Lease Obligation: 197630.00
EMD.AX balance_sheet (annual, 2021-06-30) — Current Liabilities: 1032273.00
EMD.AX income_statement (annual, 2021-06-30) — Depreciation Amortization Depletion Income Statement: 344875.00
EMD.AX income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 344875.00
EMD.AX income_statement (annual, 2021-06-30) — Depreciation Income Statement: 277861.00
EMD.AX income_statement (annual, 2021-06-30) — EBIT: -4839383.00
EMD.AX income_statement (annual, 2021-06-30) — EBITDA: -4494508.00
EMD.AX cash_flow (annual, 2021-06-30) — End Cash Position: 6528926.00
EMD.AX cash_flow (annual, 2021-06-30) — Financing Cash Flow: 7441298.00
EMD.AX cash_flow (annual, 2021-06-30) — Free Cash Flow: -4598705.00
EMD.AX balance_sheet (annual, 2021-06-30) — Gains Losses Not Affecting Retained Earnings: 826746.00
EMD.AX income_statement (annual, 2021-06-30) — General And Administrative Expense: 1947629.00
EMD.AX balance_sheet (annual, 2021-06-30) — Goodwill And Other Intangible Assets: 733630.00
EMD.AX balance_sheet (annual, 2021-06-30) — Gross PPE: 2083455.00
EMD.AX income_statement (annual, 2021-06-30) — Gross Profit: -1056729.00
EMD.AX income_statement (annual, 2021-06-30) — Interest Expense: 66851.00
EMD.AX income_statement (annual, 2021-06-30) — Interest Expense Non Operating: 66851.00
EMD.AX income_statement (annual, 2021-06-30) — Interest Income: 23148.00
EMD.AX income_statement (annual, 2021-06-30) — Interest Income Non Operating: 23148.00
EMD.AX cash_flow (annual, 2021-06-30) — Interest Paid Direct: -34533.00
EMD.AX cash_flow (annual, 2021-06-30) — Interest Paid Supplemental Data: 34533.00
EMD.AX cash_flow (annual, 2021-06-30) — Interest Received Direct: 22979.00
EMD.AX balance_sheet (annual, 2021-06-30) — Invested Capital: 7178217.00
EMD.AX cash_flow (annual, 2021-06-30) — Investing Cash Flow: -661386.00
EMD.AX cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 8400000.00
EMD.AX balance_sheet (annual, 2021-06-30) — Leases: 661249.00
EMD.AX balance_sheet (annual, 2021-06-30) — Long Term Capital Lease Obligation: 752069.00
EMD.AX balance_sheet (annual, 2021-06-30) — Long Term Debt And Capital Lease Obligation: 752069.00
EMD.AX cash_flow (annual, 2021-06-30) — Long Term Debt Payments: -240221.00
EMD.AX balance_sheet (annual, 2021-06-30) — Long Term Provisions: 97000.00
EMD.AX balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 92792.00
EMD.AX cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 7872496.00
EMD.AX income_statement (annual, 2021-06-30) — Net Income: -4906234.00
EMD.AX income_statement (annual, 2021-06-30) — Net Income Common Stockholders: -4906234.00
EMD.AX income_statement (annual, 2021-06-30) — Net Income Continuous Operations: -4906234.00
EMD.AX income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: -4906234.00
EMD.AX income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: -4906234.00
EMD.AX income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: -4906234.00
EMD.AX cash_flow (annual, 2021-06-30) — Net Intangibles Purchase And Sale: -653334.00
EMD.AX income_statement (annual, 2021-06-30) — Net Interest Income: -43703.00
EMD.AX cash_flow (annual, 2021-06-30) — Net Issuance Payments Of Debt: -240221.00
EMD.AX cash_flow (annual, 2021-06-30) — Net Long Term Debt Issuance: -240221.00
EMD.AX income_statement (annual, 2021-06-30) — Net Non Operating Interest Income Expense: -43703.00
EMD.AX cash_flow (annual, 2021-06-30) — Net Other Financing Charges: -376648.00
EMD.AX balance_sheet (annual, 2021-06-30) — Net PPE: 1280135.00
EMD.AX cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: -8052.00
EMD.AX balance_sheet (annual, 2021-06-30) — Net Tangible Assets: 6444587.00
EMD.AX income_statement (annual, 2021-06-30) — Normalized EBITDA: -4494508.00
EMD.AX income_statement (annual, 2021-06-30) — Normalized Income: -4906234.00
EMD.AX income_statement (annual, 2021-06-30) — Operating Income: -6479203.00
EMD.AX income_statement (annual, 2021-06-30) — Operating Revenue: 1207543.00
EMD.AX balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 255974018.00
EMD.AX cash_flow (annual, 2021-06-30) — Other Cash Receiptsfrom Operating Activities: 954180.00
EMD.AX balance_sheet (annual, 2021-06-30) — Other Equity Adjustments: 826746.00
EMD.AX income_statement (annual, 2021-06-30) — Other Gand A: 566674.00
EMD.AX income_statement (annual, 2021-06-30) — Other Income Expense: 1616672.00
EMD.AX balance_sheet (annual, 2021-06-30) — Other Intangible Assets: 733630.00
EMD.AX balance_sheet (annual, 2021-06-30) — Other Non Current Assets: 161864.00
EMD.AX income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 1616672.00
EMD.AX income_statement (annual, 2021-06-30) — Other Operating Expenses: 511002.00
EMD.AX balance_sheet (annual, 2021-06-30) — Other Payable: 433003.00
EMD.AX balance_sheet (annual, 2021-06-30) — Other Properties: 1329414.00
EMD.AX balance_sheet (annual, 2021-06-30) — Other Receivables: 133829.00
EMD.AX balance_sheet (annual, 2021-06-30) — Payables: 678523.00
EMD.AX balance_sheet (annual, 2021-06-30) — Payables And Accrued Expenses: 678523.00
EMD.AX cash_flow (annual, 2021-06-30) — Paymentsto Suppliersfor Goodsand Services: -6887133.00
EMD.AX balance_sheet (annual, 2021-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 156120.00
EMD.AX balance_sheet (annual, 2021-06-30) — Prepaid Assets: 81600.00
EMD.AX income_statement (annual, 2021-06-30) — Pretax Income: -4906234.00
EMD.AX cash_flow (annual, 2021-06-30) — Purchase Of Intangibles: -653334.00
EMD.AX cash_flow (annual, 2021-06-30) — Purchase Of PPE: -8052.00
EMD.AX cash_flow (annual, 2021-06-30) — Receiptsfrom Customers: 2007188.00
EMD.AX balance_sheet (annual, 2021-06-30) — Receivables: 273404.00
EMD.AX income_statement (annual, 2021-06-30) — Reconciled Cost Of Revenue: 2264272.00
EMD.AX income_statement (annual, 2021-06-30) — Reconciled Depreciation: 344875.00
EMD.AX cash_flow (annual, 2021-06-30) — Repayment Of Debt: -240221.00
EMD.AX cash_flow (annual, 2021-06-30) — Repurchase Of Capital Stock: -527504.00
EMD.AX income_statement (annual, 2021-06-30) — Research And Development: 2618968.00
EMD.AX balance_sheet (annual, 2021-06-30) — Retained Earnings: -12959333.00
EMD.AX income_statement (annual, 2021-06-30) — Salaries And Wages: 1380955.00
EMD.AX income_statement (annual, 2021-06-30) — Selling General And Administration: 1947629.00
EMD.AX balance_sheet (annual, 2021-06-30) — Share Issued: 255974018.00
EMD.AX balance_sheet (annual, 2021-06-30) — Stockholders Equity: 7178217.00
EMD.AX balance_sheet (annual, 2021-06-30) — Tangible Book Value: 6444587.00
EMD.AX income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 0.00
EMD.AX income_statement (annual, 2021-06-30) — Tax Provision: 0.00
EMD.AX income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.00
EMD.AX balance_sheet (annual, 2021-06-30) — Total Assets: 9059559.00
EMD.AX balance_sheet (annual, 2021-06-30) — Total Capitalization: 7178217.00
EMD.AX balance_sheet (annual, 2021-06-30) — Total Debt: 949699.00
EMD.AX balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 7178217.00
EMD.AX balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 1881342.00
EMD.AX balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 2175629.00
EMD.AX balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 849069.00
EMD.AX balance_sheet (annual, 2021-06-30) — Working Capital: 5851657.00
EMD.AX income_statement (annual, 2022-06-30) — +Operating Expense: 8013081.00
EMD.AX income_statement (annual, 2022-06-30) — +Total Revenue: 1352592.00
EMD.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 619142.00
EMD.AX balance_sheet (annual, 2022-06-30) — Accounts Receivable: 28423.00
EMD.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -1026511.00
EMD.AX income_statement (annual, 2022-06-30) — Amortization: 80508.00
EMD.AX income_statement (annual, 2022-06-30) — Amortization Of Intangibles Income Statement: 80508.00
EMD.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 268611782.00
EMD.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.03
EMD.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 6528926.00
EMD.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -2029186.00
EMD.AX balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 632703.00
EMD.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 24637314.00
EMD.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 3879469.00
EMD.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 3879469.00
EMD.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 3879469.00
EMD.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 4807550.00
EMD.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -2029185.00
EMD.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -5427822.00
EMD.AX cash_flow (annual, 2022-06-30) — Changes In Cash: -2649457.00
EMD.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -8484173.00
EMD.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 3096046.00
EMD.AX balance_sheet (annual, 2022-06-30) — Common Stock: 24637314.00
EMD.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 6321857.00
EMD.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 5039689.00
EMD.AX income_statement (annual, 2022-06-30) — Cost Of Revenue: 2347654.00
EMD.AX balance_sheet (annual, 2022-06-30) — Current Assets: 4115202.00
EMD.AX balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 268887.00
EMD.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 268887.00
EMD.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 1455162.00
EMD.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 390003.00
EMD.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 390003.00
EMD.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 309495.00
EMD.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 268611782.00
EMD.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.03
EMD.AX income_statement (annual, 2022-06-30) — EBIT: -7255467.00
EMD.AX income_statement (annual, 2022-06-30) — EBITDA: -6865464.00
EMD.AX cash_flow (annual, 2022-06-30) — End Cash Position: 3879469.00
EMD.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 4807550.00
EMD.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -7457008.00
EMD.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 1971567.00
EMD.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 4605485.00
EMD.AX balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 2894905.00
EMD.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 2102937.00
EMD.AX income_statement (annual, 2022-06-30) — Gross Profit: -995062.00
EMD.AX income_statement (annual, 2022-06-30) — Interest Expense: 72224.00
EMD.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 72224.00
EMD.AX income_statement (annual, 2022-06-30) — Interest Income: 12713.00
EMD.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 12713.00
EMD.AX cash_flow (annual, 2022-06-30) — Interest Paid Direct: -52254.00
EMD.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 52254.00
EMD.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 12559.00
EMD.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 6321857.00
EMD.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -2029185.00
EMD.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 5039689.00
EMD.AX balance_sheet (annual, 2022-06-30) — Leases: 672383.00
EMD.AX balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 363816.00
EMD.AX balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 363816.00
EMD.AX balance_sheet (annual, 2022-06-30) — Long Term Provisions: 107000.00
EMD.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 134506.00
EMD.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 5039689.00
EMD.AX income_statement (annual, 2022-06-30) — Net Income: -7327691.00
EMD.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -7327691.00
EMD.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -7327691.00
EMD.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -7327691.00
EMD.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -7327691.00
EMD.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -7327691.00
EMD.AX cash_flow (annual, 2022-06-30) — Net Intangibles Purchase And Sale: -1976338.00
EMD.AX income_statement (annual, 2022-06-30) — Net Interest Income: -59511.00
EMD.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -59511.00
EMD.AX cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -464840.00
EMD.AX cash_flow (annual, 2022-06-30) — Net Other Investing Changes: 1.00
EMD.AX balance_sheet (annual, 2022-06-30) — Net PPE: 1076426.00
EMD.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -52848.00
EMD.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 3426952.00
EMD.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -6865464.00
EMD.AX income_statement (annual, 2022-06-30) — Normalized Income: -7327691.00
EMD.AX income_statement (annual, 2022-06-30) — Operating Income: -9008143.00
EMD.AX income_statement (annual, 2022-06-30) — Operating Revenue: 1352592.00
EMD.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 277039524.00
EMD.AX cash_flow (annual, 2022-06-30) — Other Cash Receiptsfrom Operating Activities: 1162135.00
EMD.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 1971567.00
EMD.AX income_statement (annual, 2022-06-30) — Other Gand A: 1106543.00
EMD.AX income_statement (annual, 2022-06-30) — Other Income Expense: 1739963.00
EMD.AX balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 2894905.00
EMD.AX balance_sheet (annual, 2022-06-30) — Other Non Current Assets: 161302.00
EMD.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 1739963.00
EMD.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 808728.00
EMD.AX balance_sheet (annual, 2022-06-30) — Other Payable: 369747.00
EMD.AX balance_sheet (annual, 2022-06-30) — Other Properties: 1296048.00
EMD.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 59064.00
EMD.AX balance_sheet (annual, 2022-06-30) — Payables: 988889.00
EMD.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 988889.00
EMD.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -8484173.00
EMD.AX balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 197386.00
EMD.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 148246.00
EMD.AX income_statement (annual, 2022-06-30) — Pretax Income: -7327691.00
EMD.AX cash_flow (annual, 2022-06-30) — Purchase Of Intangibles: -1976338.00
EMD.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -52848.00
EMD.AX cash_flow (annual, 2022-06-30) — Receiptsfrom Customers: 1933911.00
EMD.AX balance_sheet (annual, 2022-06-30) — Receivables: 87487.00
EMD.AX income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 2347654.00
EMD.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 390003.00
EMD.AX income_statement (annual, 2022-06-30) — Research And Development: 2208865.00
EMD.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -20287024.00
EMD.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 3498942.00
EMD.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 4605485.00
EMD.AX balance_sheet (annual, 2022-06-30) — Share Issued: 277039524.00
EMD.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 6321857.00
EMD.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 3426952.00
EMD.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
EMD.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
EMD.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
EMD.AX balance_sheet (annual, 2022-06-30) — Total Assets: 8247835.00
EMD.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 6321857.00
EMD.AX balance_sheet (annual, 2022-06-30) — Total Debt: 632703.00
EMD.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 6321857.00
EMD.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 1925978.00
EMD.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 4132633.00
EMD.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 470816.00
EMD.AX balance_sheet (annual, 2022-06-30) — Working Capital: 2660040.00
EMD.AX income_statement (annual, 2023-06-30) — +Operating Expense: 6470350.00
EMD.AX income_statement (annual, 2023-06-30) — +Total Revenue: 1592466.00
EMD.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 1829194.00
EMD.AX balance_sheet (annual, 2023-06-30) — Accounts Receivable: 85482.00
EMD.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -1015045.00
EMD.AX income_statement (annual, 2023-06-30) — Amortization: 80508.00
EMD.AX income_statement (annual, 2023-06-30) — Amortization Of Intangibles Income Statement: 80508.00
EMD.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 289386834.00
EMD.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.02
EMD.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 3879469.00
EMD.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -3233717.00
EMD.AX balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 358407.00
EMD.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 29803915.00
EMD.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 2733526.00
EMD.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 2733526.00
EMD.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 2733526.00
EMD.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 5842543.00
EMD.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -3233717.00
EMD.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -3754769.00
EMD.AX cash_flow (annual, 2023-06-30) — Changes In Cash: -1145943.00
EMD.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -7601032.00
EMD.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: 3905997.00
EMD.AX balance_sheet (annual, 2023-06-30) — Common Stock: 29803915.00
EMD.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 6793615.00
EMD.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 5500000.00
EMD.AX cash_flow (annual, 2023-06-30) — Common Stock Payments: -320000.00
EMD.AX income_statement (annual, 2023-06-30) — Cost Of Revenue: 2239975.00
EMD.AX balance_sheet (annual, 2023-06-30) — Current Assets: 2906915.00
EMD.AX balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 218284.00
EMD.AX balance_sheet (annual, 2023-06-30) — Current Debt: 912721.00
EMD.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 1131005.00
EMD.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 4028944.00
EMD.AX balance_sheet (annual, 2023-06-30) — Current Provisions: 189021.00
EMD.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 400601.00
EMD.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 400601.00
EMD.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 320093.00
EMD.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 289386834.00
EMD.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.02
EMD.AX income_statement (annual, 2023-06-30) — EBIT: -5002324.00
EMD.AX income_statement (annual, 2023-06-30) — EBITDA: -4601723.00
EMD.AX cash_flow (annual, 2023-06-30) — End Cash Position: 2733526.00
EMD.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 5842543.00
EMD.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -6988486.00
EMD.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 2407841.00
EMD.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 3425629.00
EMD.AX balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 6671143.00
EMD.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 1511010.00
EMD.AX income_statement (annual, 2023-06-30) — Gross Profit: -647509.00
EMD.AX income_statement (annual, 2023-06-30) — Interest Expense: 128793.00
EMD.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 128793.00
EMD.AX income_statement (annual, 2023-06-30) — Interest Income: 30333.00
EMD.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 30333.00
EMD.AX cash_flow (annual, 2023-06-30) — Interest Paid Direct: -84225.00
EMD.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 84225.00
EMD.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 24491.00
EMD.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 7706336.00
EMD.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -3233717.00
EMD.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 5500000.00
EMD.AX cash_flow (annual, 2023-06-30) — Issuance Of Debt: 1719928.00
EMD.AX balance_sheet (annual, 2023-06-30) — Leases: 412173.00
EMD.AX balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 140123.00
EMD.AX balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 140123.00
EMD.AX cash_flow (annual, 2023-06-30) — Long Term Debt Issuance: 1719928.00
EMD.AX cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -800000.00
EMD.AX balance_sheet (annual, 2023-06-30) — Long Term Provisions: 81000.00
EMD.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 132354.00
EMD.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 5180000.00
EMD.AX income_statement (annual, 2023-06-30) — Net Income: -5131117.00
EMD.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -5131117.00
EMD.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -5131117.00
EMD.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -5131117.00
EMD.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -5131117.00
EMD.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -5131117.00
EMD.AX cash_flow (annual, 2023-06-30) — Net Intangibles Purchase And Sale: -3216895.00
EMD.AX income_statement (annual, 2023-06-30) — Net Interest Income: -98460.00
EMD.AX cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: 919928.00
EMD.AX cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: 919928.00
EMD.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: -98460.00
EMD.AX cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -834769.00
EMD.AX balance_sheet (annual, 2023-06-30) — Net PPE: 495965.00
EMD.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -16822.00
EMD.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 122472.00
EMD.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -4475656.00
EMD.AX income_statement (annual, 2023-06-30) — Normalized Income: -5005050.00
EMD.AX income_statement (annual, 2023-06-30) — Operating Income: -7117859.00
EMD.AX income_statement (annual, 2023-06-30) — Operating Revenue: 1592466.00
EMD.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 310633381.00
EMD.AX cash_flow (annual, 2023-06-30) — Other Cash Receiptsfrom Operating Activities: 2089732.00
EMD.AX balance_sheet (annual, 2023-06-30) — Other Current Borrowings: 912721.00
EMD.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 2407841.00
EMD.AX income_statement (annual, 2023-06-30) — Other Gand A: 1152445.00
EMD.AX income_statement (annual, 2023-06-30) — Other Income Expense: 2085202.00
EMD.AX balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 6671143.00
EMD.AX balance_sheet (annual, 2023-06-30) — Other Non Current Assets: 144582.00
EMD.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 2211269.00
EMD.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 845617.00
EMD.AX balance_sheet (annual, 2023-06-30) — Other Payable: 706425.00
EMD.AX balance_sheet (annual, 2023-06-30) — Other Properties: 966483.00
EMD.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 54647.00
EMD.AX income_statement (annual, 2023-06-30) — Other Special Charges: 126067.00
EMD.AX balance_sheet (annual, 2023-06-30) — Payables: 2535619.00
EMD.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 2535619.00
EMD.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -7601032.00
EMD.AX balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 173299.00
EMD.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 33260.00
EMD.AX income_statement (annual, 2023-06-30) — Pretax Income: -5131117.00
EMD.AX cash_flow (annual, 2023-06-30) — Purchase Of Intangibles: -3216895.00
EMD.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -16822.00
EMD.AX cash_flow (annual, 2023-06-30) — Receiptsfrom Customers: 1816265.00
EMD.AX balance_sheet (annual, 2023-06-30) — Receivables: 140129.00
EMD.AX income_statement (annual, 2023-06-30) — Reconciled Cost Of Revenue: 2239975.00
EMD.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 400601.00
EMD.AX cash_flow (annual, 2023-06-30) — Repayment Of Debt: -800000.00
EMD.AX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -320000.00
EMD.AX income_statement (annual, 2023-06-30) — Research And Development: 1798503.00
EMD.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -25418141.00
EMD.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 2273184.00
EMD.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 3425629.00
EMD.AX balance_sheet (annual, 2023-06-30) — Share Issued: 310633381.00
EMD.AX income_statement (annual, 2023-06-30) — Special Income Charges: -126067.00
EMD.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 6793615.00
EMD.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 122472.00
EMD.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
EMD.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
EMD.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
EMD.AX balance_sheet (annual, 2023-06-30) — Total Assets: 10218605.00
EMD.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 6793615.00
EMD.AX balance_sheet (annual, 2023-06-30) — Total Debt: 1271128.00
EMD.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 6793615.00
EMD.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 4250067.00
EMD.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 7311690.00
EMD.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 221123.00
EMD.AX income_statement (annual, 2023-06-30) — Total Unusual Items: -126067.00
EMD.AX income_statement (annual, 2023-06-30) — Total Unusual Items Excluding Goodwill: -126067.00
EMD.AX balance_sheet (annual, 2023-06-30) — Working Capital: -1122029.00
EMD.AX income_statement (annual, 2024-06-30) — +Operating Expense: 6735130.00
EMD.AX income_statement (annual, 2024-06-30) — +Total Revenue: 2202717.00
EMD.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 504033.00
EMD.AX balance_sheet (annual, 2024-06-30) — Accounts Receivable: 27258.00
EMD.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -1294867.00
EMD.AX income_statement (annual, 2024-06-30) — Amortization: 292476.00
EMD.AX income_statement (annual, 2024-06-30) — Amortization Of Intangibles Income Statement: 292476.00
EMD.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 358968879.00
EMD.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.03
EMD.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 2733526.00
EMD.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -1238213.00
EMD.AX balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 905009.00
EMD.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 36261053.00
EMD.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 1566211.00
EMD.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 1566211.00
EMD.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 1566211.00
EMD.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 4495172.00
EMD.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -1377713.00
EMD.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -4284774.00
EMD.AX cash_flow (annual, 2024-06-30) — Changes In Cash: -1167315.00
EMD.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -8970693.00
EMD.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 4809772.00
EMD.AX balance_sheet (annual, 2024-06-30) — Common Stock: 36261053.00
EMD.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 2425360.00
EMD.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 5158231.00
EMD.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -139360.00
EMD.AX income_statement (annual, 2024-06-30) — Cost Of Revenue: 2370265.00
EMD.AX balance_sheet (annual, 2024-06-30) — Current Assets: 1927999.00
EMD.AX balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 217671.00
EMD.AX balance_sheet (annual, 2024-06-30) — Current Debt: 813675.00
EMD.AX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 1031346.00
EMD.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 2240914.00
EMD.AX balance_sheet (annual, 2024-06-30) — Current Provisions: 15268.00
EMD.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 694908.00
EMD.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 694908.00
EMD.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 402432.00
EMD.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 358968879.00
EMD.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.03
EMD.AX income_statement (annual, 2024-06-30) — EBIT: -11202448.00
EMD.AX income_statement (annual, 2024-06-30) — EBITDA: -10507540.00
EMD.AX cash_flow (annual, 2024-06-30) — End Cash Position: 1566211.00
EMD.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 4495172.00
EMD.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -5522987.00
EMD.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 1514617.00
EMD.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 3426960.00
EMD.AX balance_sheet (annual, 2024-06-30) — Goodwill: 1561471.00
EMD.AX balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 2083514.00
EMD.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 2558908.00
EMD.AX income_statement (annual, 2024-06-30) — Gross Profit: -167548.00
EMD.AX income_statement (annual, 2024-06-30) — Impairment Of Capital Assets: 6935740.00
EMD.AX income_statement (annual, 2024-06-30) — Interest Expense: 253306.00
EMD.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 253306.00
EMD.AX income_statement (annual, 2024-06-30) — Interest Income: 21563.00
EMD.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 21563.00
EMD.AX cash_flow (annual, 2024-06-30) — Interest Paid Direct: -145416.00
EMD.AX cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 145416.00
EMD.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 21563.00
EMD.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 3239035.00
EMD.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -1377713.00
EMD.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 5158231.00
EMD.AX cash_flow (annual, 2024-06-30) — Issuance Of Debt: 1803197.00
EMD.AX balance_sheet (annual, 2024-06-30) — Leases: 765470.00
EMD.AX balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 687338.00
EMD.AX balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 687338.00
EMD.AX cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 1803197.00
EMD.AX cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -2083051.00
EMD.AX balance_sheet (annual, 2024-06-30) — Long Term Provisions: 72000.00
EMD.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 194384.00
EMD.AX cash_flow (annual, 2024-06-30) — Net Business Purchase And Sale: -139500.00
EMD.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 5018871.00
EMD.AX income_statement (annual, 2024-06-30) — Net Income: -11455754.00
EMD.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -11455754.00
EMD.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -11455754.00
EMD.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -11455754.00
EMD.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -11455754.00
EMD.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -11455754.00
EMD.AX cash_flow (annual, 2024-06-30) — Net Intangibles Purchase And Sale: -1079116.00
EMD.AX income_statement (annual, 2024-06-30) — Net Interest Income: -231743.00
EMD.AX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: -279854.00
EMD.AX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: -279854.00
EMD.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -231743.00
EMD.AX cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -487690.00
EMD.AX balance_sheet (annual, 2024-06-30) — Net PPE: 1264041.00
EMD.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -159097.00
EMD.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 341846.00
EMD.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -3571220.00
EMD.AX income_statement (annual, 2024-06-30) — Normalized Income: -4519434.00
EMD.AX income_statement (annual, 2024-06-30) — Operating Income: -6902678.00
EMD.AX income_statement (annual, 2024-06-30) — Operating Revenue: 2202717.00
EMD.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 408989396.00
EMD.AX cash_flow (annual, 2024-06-30) — Other Cash Receiptsfrom Operating Activities: 2527317.00
EMD.AX balance_sheet (annual, 2024-06-30) — Other Current Borrowings: 813675.00
EMD.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 1514617.00
EMD.AX income_statement (annual, 2024-06-30) — Other Gand A: 1452599.00
EMD.AX income_statement (annual, 2024-06-30) — Other Income Expense: -4321333.00
EMD.AX balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 522043.00
EMD.AX balance_sheet (annual, 2024-06-30) — Other Non Current Assets: 150058.00
EMD.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 2614987.00
EMD.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 526372.00
EMD.AX balance_sheet (annual, 2024-06-30) — Other Payable: 544736.00
EMD.AX balance_sheet (annual, 2024-06-30) — Other Properties: 1599054.00
EMD.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 3406.00
EMD.AX income_statement (annual, 2024-06-30) — Other Special Charges: 580.00
EMD.AX balance_sheet (annual, 2024-06-30) — Payables: 1048769.00
EMD.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 1048769.00
EMD.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -8970693.00
EMD.AX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 145531.00
EMD.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 331124.00
EMD.AX income_statement (annual, 2024-06-30) — Pretax Income: -11455754.00
EMD.AX cash_flow (annual, 2024-06-30) — Purchase Of Business: -139500.00
EMD.AX cash_flow (annual, 2024-06-30) — Purchase Of Intangibles: -1079116.00
EMD.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -159097.00
EMD.AX cash_flow (annual, 2024-06-30) — Receiptsfrom Customers: 2282455.00
EMD.AX balance_sheet (annual, 2024-06-30) — Receivables: 30664.00
EMD.AX income_statement (annual, 2024-06-30) — Reconciled Cost Of Revenue: 2370265.00
EMD.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 694908.00
EMD.AX cash_flow (annual, 2024-06-30) — Repayment Of Debt: -2083051.00
EMD.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -139360.00
EMD.AX income_statement (annual, 2024-06-30) — Research And Development: 2086890.00
EMD.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -35350310.00
EMD.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 1974361.00